English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

To better understand the relation of cytomegalovirus (CMV)-specific CD4+ T lymphocyte immunity and clinical outcome in AIDS-related CMV end-organ disease, 2 patient groups were prospectively studied: patients recently diagnosed with active CMV end-organ disease and survivors of CMV retinitis who had responded to highly active antiretroviral therapy and had quiescent retinitis when anti-CMV therapy was discontinued. Most patients with active CMV disease had negative CMV-specific CD4+ T lymphocyte responses at diagnosis, as measured by lymphoproliferation (7/7) or cytokine flow cytometry (3/5) assays. In contrast, all 10 subjects with quiescent retinitis and &gt;150 absolute CD4+ T lymphocytes/microL whose anti-CMV therapy was discontinued during 6 months of follow-up had positive CMV-specific immune responses at least once by each assay. However, 6 of these 10 subjects also had negative CMV-specific immune responses &gt; or =1 time. Such patients may be at risk for future CMV disease progression and should be closely monitored.

the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases

Cytomegalovirus (CMV)–Specific CD4<sup>+</sup>T Lymphocyte Immune Function in Long‐Term Survivors of AIDS‐Related CMV End‐Organ Disease Who Are Receiving Potent Antiretroviral Therapy

Cytomegalovirus (CMV)–Specific CD4+T Lymphocyte Immune Function in Long‐Term Survivors of AIDS‐Related CMV End‐Organ Disease Who Are Receiving Potent Antiretroviral Therapy

Cytomegalovirus (CMV)–Specific CD4⁺T Lymphocyte Immune Function in Long‐Term Survivors of AIDS‐Related CMV End‐Organ Disease Who Are Receiving Potent Antiretroviral Therapy